Year To Quarter End Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7726293

Concept 2017-03-01 to
2018-02-28
2017-03-01 to
2018-02-28
2017-03-01 to
2018-02-28
2017-03-01 to
2018-02-28
2017-03-01 to
2018-02-28
2017-03-01 to
2018-02-28
2017-03-01 to
2018-02-28
2016-03-01 to
2017-02-28
2016-03-01 to
2017-02-28
2016-03-01 to
2017-02-28
2016-03-01 to
2017-02-28
2016-03-01 to
2017-02-28
2016-03-01 to
2017-02-28
2016-03-01 to
2017-02-28
Year to quarter end consolidated statement of income
Statement of income
Net sales
147,870,000,000 JPY
112,391,000,000 JPY
145,925,000,000 JPY
112,671,000,000 JPY
Cost of sales
55,688,000,000 JPY
40,238,000,000 JPY
53,155,000,000 JPY
40,560,000,000 JPY
Gross profit (loss)
92,182,000,000 JPY
72,152,000,000 JPY
92,770,000,000 JPY
72,111,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
10,987,000,000 JPY
9,661,000,000 JPY
Salaries
5,140,000,000 JPY
5,013,000,000 JPY
Bonuses
1,240,000,000 JPY
1,246,000,000 JPY
Taxes and dues
646,000,000 JPY
398,000,000 JPY
Depreciation
1,424,000,000 JPY
1,419,000,000 JPY
Amortization of goodwill
JPY
930,000,000 JPY
Selling, general and administrative expenses
65,836,000,000 JPY
51,636,000,000 JPY
66,464,000,000 JPY
50,567,000,000 JPY
Operating profit (loss)
26,345,000,000 JPY
20,516,000,000 JPY
26,306,000,000 JPY
21,543,000,000 JPY
Non-operating income
Interest income
493,000,000 JPY
18,000,000 JPY
292,000,000 JPY
24,000,000 JPY
Dividend income
724,000,000 JPY
899,000,000 JPY
675,000,000 JPY
783,000,000 JPY
Share of profit of entities accounted for using equity method
129,000,000 JPY
471,000,000 JPY
Non-operating income
2,398,000,000 JPY
1,235,000,000 JPY
2,034,000,000 JPY
1,233,000,000 JPY
Non-operating expenses
Interest expenses
32,000,000 JPY
39,000,000 JPY
Non-operating expenses
498,000,000 JPY
382,000,000 JPY
160,000,000 JPY
69,000,000 JPY
Ordinary profit (loss)
28,245,000,000 JPY
21,369,000,000 JPY
28,179,000,000 JPY
22,706,000,000 JPY
Extraordinary income
Extraordinary income
487,000,000 JPY
487,000,000 JPY
4,231,000,000 JPY
1,317,000,000 JPY
Extraordinary losses
Impairment losses
1,023,000,000 JPY
1,023,000,000 JPY
2,354,000,000 JPY
JPY
Extraordinary losses
1,038,000,000 JPY
1,034,000,000 JPY
2,426,000,000 JPY
47,000,000 JPY
Profit (loss) before income taxes
27,694,000,000 JPY
20,822,000,000 JPY
29,984,000,000 JPY
23,976,000,000 JPY
Income taxes - current
9,261,000,000 JPY
7,583,000,000 JPY
7,287,000,000 JPY
6,759,000,000 JPY
Income taxes - deferred
-893,000,000 JPY
-1,382,000,000 JPY
2,155,000,000 JPY
474,000,000 JPY
Income taxes
8,367,000,000 JPY
6,200,000,000 JPY
9,443,000,000 JPY
7,234,000,000 JPY
Profit (loss)
14,621,000,000 JPY
19,327,000,000 JPY
14,621,000,000 JPY
14,621,000,000 JPY
14,621,000,000 JPY
16,741,000,000 JPY
16,741,000,000 JPY
20,541,000,000 JPY
16,741,000,000 JPY
16,741,000,000 JPY
Profit attributable to
Profit (loss) attributable to non-controlling interests
207,000,000 JPY
146,000,000 JPY
Profit (loss) attributable to owners of parent
19,119,000,000 JPY
19,119,000,000 JPY
19,119,000,000 JPY
20,395,000,000 JPY
20,395,000,000 JPY
20,395,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
4,453,000,000 JPY
1,119,000,000 JPY
Foreign currency translation adjustment
-1,833,000,000 JPY
-1,454,000,000 JPY
Remeasurements of defined benefit plans, net of tax
791,000,000 JPY
838,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
113,000,000 JPY
26,000,000 JPY
Other comprehensive income
3,525,000,000 JPY
614,000,000 JPY
Comprehensive income
22,852,000,000 JPY
21,156,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
22,662,000,000 JPY
21,008,000,000 JPY
Comprehensive income attributable to non-controlling interests
189,000,000 JPY
147,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.